20Feb 2025
HPV-Positive Penile Cancer: Optimizing Treatment With Targeted Therapies

HPV-Positive Penile Cancer: Optimizing Treatment With Targeted Therapies

Penile squamous cell carcinoma (PSCC) is linked to HPV infection, particularly HPV-16, influencing treatment response. HPV-positive PSCC shows enhanced sensitivity to chemoradiotherapy and immunotherapy, suggesting potential for treatment de-escalation. Biomarkers like tumor mutational burden and PD-L1 expression may guide personalized strategies. Tailored therapies integrating immunotherapy with radiotherapy could improve outcomes while minimizing toxicity, highlighting the need for comprehensive HPV status assessment in treatment planning.

  • #urology

Like

Save

Share